Keith Phillips

Keith Phillips has a diverse work experience starting from their student placement at Eli Lilly in 2002. Keith then moved on to University of Bristol as a Postdoctoral Research Fellow before joining Eli Lilly and Company in various roles from Research Scientist to Associate Vice President. Currently, they hold the position of Vice President, Head of Novel Therapeutic Modalities at Grünenthal Group.

Keith Phillips completed their BSc in Pharmacology at the University of Southampton from 1999 to 2004. Keith then went on to earn their PhD in Neuroscience from Cardiff University / Prifysgol Caerdydd from 2003 to 2007.